迪安诊断预计2025年净利2800万元至4200万元，同比扭亏

Core Viewpoint - Dian Diagnostics (300244) is expected to achieve a net profit attributable to shareholders of between 28 million and 42 million yuan in 2025, marking a turnaround from losses to profitability [2] Group 1: Financial Performance - The company anticipates a significant improvement in financial performance, with a projected net profit range of 28 million to 42 million yuan for 2025 [2] - Operating cash flow is expected to increase to approximately 1.8 billion yuan, indicating a positive trend in operational efficiency [2] Group 2: Strategic Focus - The company is focusing on enhancing operational quality by targeting high-value clients and strengthening the promotion of specialized tests and proprietary products [2] - There is a commitment to deepening regional integrated operations and solidifying market coverage, with a steady increase in the number of new clients [2] Group 3: Innovation and Technology - Dian Diagnostics is accelerating the commercialization of AI products, achieving breakthroughs in data operations, medical device registration, and overseas business expansion [2] - These advancements are expected to inject strong new momentum into the company's high-quality development [2]